Rick E Winningham Theravance Biopharma, Inc. (TBPH) insider trading activity

Rick E Winningham is CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 1.82 Million shares of TBPH, which is worth approximately $15 Million. The most recent transaction as insider was on Aug 20, 2024, when has been sold 15,997 shares (Ordinary Shares) at a price of $8.22 per share, resulting in proceeds of $131,495. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.82M

0.69% 3M change

13.16% 12M change

Total Value Held $15 Million

Rick E Winningham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2024	SELL Payment of exercise price or tax liability	$131,495 $8.22 p/Share	15,997 Reduced 0.87%	1,823,899 Ordinary Shares
Aug 07 2024	BUY Grant, award, or other acquisition	$25,463 $7.83 p/Share	3,252 Added 0.18%	1,839,896 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$145,572 $9.1 p/Share	15,997 Reduced 0.86%	1,836,644 Ordinary Shares
May 15 2024	BUY Grant, award, or other acquisition	$20,369 $9.85 p/Share	2,068 Added 0.11%	1,852,641 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	300,000 Added 13.95%	1,850,573 Ordinary Shares
Mar 15 2024	SELL Bona fide gift	-	10,900 Reduced 0.7%	1,550,573 Ordinary Shares
Mar 15 2024	BUY Grant, award, or other acquisition	$23,362 $8.64 p/Share	2,704 Added 0.17%	1,561,473 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$331,788 $8.92 p/Share	37,196 Reduced 2.33%	1,558,769 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$163,887 $10.37 p/Share	15,804 Reduced 0.98%	1,595,965 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$153,298 $9.7 p/Share	15,804 Reduced 0.97%	1,611,769 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$177,162 $11.21 p/Share	15,804 Reduced 0.96%	1,627,573 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	330,000 Added 16.72%	1,643,377 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$390,664 $10.44 p/Share	37,420 Reduced 2.77%	1,313,377 Ordinary Shares
Dec 14 2022	SELL Open market or private sale	$559,500 $11.19 p/Share	50,000 Reduced 3.57%	1,350,797 Ordinary Shares
Dec 13 2022	SELL Bona fide gift	-	9,000 Reduced 0.64%	1,400,797 Ordinary Shares
Nov 20 2022	SELL Payment of exercise price or tax liability	$171,473 $10.85 p/Share	15,804 Reduced 1.11%	1,409,797 Ordinary Shares
Aug 19 2022	SELL Payment of exercise price or tax liability	$147,609 $9.34 p/Share	15,804 Reduced 1.1%	1,424,784 Ordinary Shares
May 20 2022	SELL Payment of exercise price or tax liability	$96,358 $8.74 p/Share	11,025 Reduced 0.76%	1,440,588 Ordinary Shares
Feb 25 2022	BUY Grant, award, or other acquisition	-	170,000 Added 10.5%	1,449,300 Ordinary Shares
Feb 18 2022	SELL Payment of exercise price or tax liability	$218,243 $9.61 p/Share	22,710 Reduced 1.74%	1,279,300 Ordinary Shares
Nov 19 2021	SELL Payment of exercise price or tax liability	$95,337 $8.36 p/Share	11,404 Reduced 0.87%	1,302,010 Ordinary Shares
Aug 20 2021	SELL Payment of exercise price or tax liability	$160,226 $14.05 p/Share	11,404 Reduced 0.86%	1,313,414 Ordinary Shares
May 20 2021	SELL Payment of exercise price or tax liability	$202,991 $17.8 p/Share	11,404 Reduced 0.85%	1,324,818 Ordinary Shares
Feb 20 2021	SELL Payment of exercise price or tax liability	$2,073,439 $18.79 p/Share	110,348 Reduced 7.64%	1,334,821 Ordinary Shares
Feb 08 2021	BUY Grant, award, or other acquisition	-	170,000 Added 10.53%	1,445,169 Ordinary Shares

Also insider at

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

REW